
NYSE:CFX
The current stock price of CFX is 39.06 null. In the past month the price increased by 7.54%. In the past year, price decreased by -10.02%.
ChartMill assigns a technical rating of 1 / 10 to CFX. When comparing the yearly performance of all stocks, CFX is a bad performer in the overall market: 61.5% of all stocks are doing better.
ChartMill assigns a fundamental rating of 3 / 10 to CFX. CFX has a bad profitability rating. Also its financial health evaluation is rather negative.
Over the last trailing twelve months CFX reported a non-GAAP Earnings per Share(EPS) of 2.13. The EPS increased by 53.24% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 1.86% | ||
| ROA | 0.84% | ||
| ROE | 1.55% | ||
| Debt/Equity | 0.45 |
19 analysts have analysed CFX and the average price target is 51.43 null. This implies a price increase of 31.66% is expected in the next year compared to the current price of 39.06.
For the next year, analysts expect an EPS growth of 241.51% and a revenue growth 7.2% for CFX
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| PH | PARKER HANNIFIN CORP | 28.4 | 125.664B | ||
| ITW | ILLINOIS TOOL WORKS | 26.54 | 86.47B | ||
| IR | INGERSOLL-RAND INC | 26.61 | 38.227B | ||
| SYM | SYMBOTIC INC | 58.13 | 35.167B | ||
| OTIS | OTIS WORLDWIDE CORP | 20.57 | 34.849B | ||
| DOV | DOVER CORP | 22.03 | 31.966B | ||
| XYL | XYLEM INC | 22.76 | 30.865B | ||
| SNA | SNAP-ON INC | 18.65 | 19.903B | ||
| FTV | FORTIVE CORP | 19.55 | 18.4B | ||
| RBC | RBC BEARINGS INC | 41.1 | 17.408B |
View all stocks in the Industrial Machinery & Supplies & Components Industry | View all stocks in the Industrials Sector | View all stocks on the New York Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
COLFAX CORP
2711 Centerville Road, Suite 400
Wilmington DELAWARE 20701 US
CEO: Matthew L. Trerotola
Employees: 16200
Phone: 13022529160.0
Colfax Corp. operates as a diversified technology company. The company is headquartered in Wilmington, Delaware and currently employs 16,200 full-time employees. The company went IPO on 2008-05-08. The Company’s segments include Fabrication Technology and Medical Technology. The Fabrication Technology segment formulates, develops, manufactures and supplies consumable products and equipment, including cutting, joining, and automated welding products, as well as gas control equipment. Its fabrication technology products are marketed under several brands, including ESAB. The Medical Technology segment develops, manufactures and distributes medical devices and services across the continuum of patient care from injury prevention to joint replacement to the rehabilitation after surgery, injury from degenerative disease, enabling people to regain or maintain their natural motion. Its products are used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, athletic trainers and other healthcare professionals.
The current stock price of CFX is 39.06 null. The price decreased by -3.77% in the last trading session.
CFX does not pay a dividend.
CFX has a ChartMill Technical rating of 1 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
CFX stock is listed on the New York Stock Exchange exchange.
The PE ratio for COLFAX CORP (CFX) is 18.34. This is based on the reported non-GAAP earnings per share of 2.13 and the current share price of 39.06 null.
COLFAX CORP (CFX) has a market capitalization of 6.10B null. This makes CFX a Mid Cap stock.